Skip to Content
Merck
All Photos(2)

Key Documents

11088939001

Roche

Tumor Necrosis Factor-α, human (hTNF-α)

recombinant (yeast)

Synonym(s):

hTNF, human necrosis factor

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352207

biological source

human

Quality Level

recombinant

expressed in yeast

Assay

≥95% (SDS-PAGE)

form

solution

potency

≤0.01 ng/mL EC50

specific activity

>1*10^8 U/mg

mol wt

17,000 Da

packaging

pkg of 1,000,000 U (10 μg, 1ml)

manufacturer/tradename

Roche

storage condition

avoid repeated freeze/thaw cycles

impurities

<0.1 EU/μgtested (LAL test)

UniProt accession no.

storage temp.

−20°C

Gene Information

human ... TNF(7124)

General description

>1 x 108 U/mg, <0.01 ng/ml (hTNF-a, NIBSC, interim standard, 87/650), at least the same specific activity (EC50) compared to the indicated standard is guaranteed.

Specificity

Human hTNF-α is effective on human and mouse cells.
Species specificity: human, mouse

Application

Tumor Necrosis Factor-α (hTNF-α)
  • Shows cytolytic and/or cytostatic activity on a variety of transformed cell lines.
  • Has activating and growth stimulating activities on a variety of normal cells.
  • Has antiviral activity on many cell types in vitro.
  • Can cause tumor necrosis of certain tumors in vivo.

Biochem/physiol Actions

Receptor p55 and p75, belonging to the TNFR gene family, mediate the biological activity of TNF-a, and are co-expressed on the surface of various cell types. The pleiotropic action of TNF-a is initiated by binding to either of the two receptors.

Quality

Purity: >95% (SDS-PAGE)
Endotoxin level: <0.1 EU/μg (LAL-test), <10 EU/ml (LAL-test)

Sequence

Chain Length 157 AA
One polypeptide chain (157 amino acids), identical to natural hTNF-α.

Unit Definition

EC50 definition: The amount of hTNF-α that is required to mediate half-maximal cytotoxicity (MTT cleavage) with WEHI 164 cells in the presence of actinomycin D (1 unit equals ≤0.01 ng/ml).

Physical form

Solution, filtered through 0.2 μm pore size membrane.

Preparation Note

Working concentration: 1 ng/ml
For complete cell lysis of sensitive cell lines about 1 ng/ml is recommended.
Working solution: Dilute the concentrated hTNF-α solution (10 μg/ml) with PBS or culture medium containing BSA (or HSA), 1 mg/ml (0.1%) or serum 1 to 10%.
Storage conditions (working solution): -15 to -25 °C
It is recommended to store the solution in aliquots at -15 to -25 °C.
Note: Avoid repeated freezing and thawing.

Other Notes

For life science research only. Not for use in diagnostic procedures. 1 EU corresponds to 0.1 ng

Storage Class Code

12 - Non Combustible Liquids

WGK

nwg

Flash Point(F)

does not flash

Flash Point(C)

does not flash


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

P De Cesaris et al.
The Journal of biological chemistry, 274(41), 28978-28982 (1999-10-03)
Tumor necrosis factor alpha (TNF-alpha) is a cytokine implicated in the pathogenesis of numerous chronic and acute inflammatory conditions. We have previously shown that mouse Sertoli cells respond to TNF-alpha by increasing interleukin-6 production and intercellular adhesion molecule-1 (ICAM-1) expression
Rajitha Indukuri et al.
Frontiers in endocrinology, 12, 650625-650625 (2021-04-17)
Inflammation is a primary component of both initiation and promotion of colorectal cancer (CRC). Cytokines secreted by macrophages, including tumor necrosis factor alpha (TNFα), activates the pro-survival transcription factor complex NFκB. The precise mechanism of NFκB in CRC is not

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service